Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I

References

• Aedo S, Melo A, Garcia P, et al. (2007). Detection and typification of human papilloma virus in pre cancerous cervical lesions. Rev Med Chil 135:167–73
   PubMedGoogle Scholar
• Bu XM, Zhao CH, Zhang N, et al. (2008). Hypermethylation and aberrant expression of secreted frizzled-related protein genes in pancreatic cancer. World J Gastroenterol 14:3421–4
   PubMedGoogle Scholar
• Burd EM. (2003). Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1–17
   PubMed Web of Science ®Google Scholar
• Chung MT, Sytwu HK, Yan MD, et al. (2009). Promoter methylation of SFRPs gene family in cervical cancer. Gynecol Oncol 112:301–6
   PubMedGoogle Scholar
• Coutlee F, Rouleau D, Ferenczy A, Franco E. (2005). The laboratory diagnosis of genital human papillomavirus infections. Can J Infect Dis Med Microbiol 16:83–91
   PubMedGoogle Scholar
• Dong SM, Kim HS, Rha SH, Sidransky D. (2001). Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7:1982–6
   PubMed Web of Science ®Google Scholar
• Drake J, Shearwood AM, White J, et al. (2009). Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours. Eur J Gynaecol Oncol 30:133–41
   PubMedGoogle Scholar
• Duenas-Gonzalez A, Lizano M, Candelaria M, et al. (2005). Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer 4:38. doi:10.1186/1476-4598-4-38
   PubMed Web of Science ®Google Scholar
• Esteller M. (2008). Epigenetics in cancer. N Engl J Med 358:1148–59
   PubMed Web of Science ®Google Scholar
• Fackler MJ, McVeigh M, Mehrotra J, et al. (2004). Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 64:4442–52
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–917
   PubMed Web of Science ®Google Scholar
• Herman JG, Graff JR, Myohanen S, et al. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821–6
   PubMed Web of Science ®Google Scholar
• Huang D, Yu B, Deng Y, et al. (2010). SFRP4 was overexpressed in colorectal carcinoma. J Cancer Res Clin Oncol 136:395–401
   PubMedGoogle Scholar
• Jastreboff AM, Cymet T. (2002). Role of the human papilloma virus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J 78:225–8
   PubMedGoogle Scholar
• Lambert MP, Herceg Z. (2008). Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007. Mol Oncol 2:33–40
   PubMed Web of Science ®Google Scholar
• Mayrand MH, Duarte-Franco E, Rodrigues I, et al. (2007). Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357:1579–88
   PubMed Web of Science ®Google Scholar
• Mulero-Navarro S, Esteller M. (2008). Epigenetic biomarkers for human cancer: the time is now. Crit Rev Oncol Hematol 68:1–11
   PubMed Web of Science ®Google Scholar
• Muñoz N, Castellsagué X, de González AB, Gissmann L. (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine 24S3:S3/1– S3/10
   Google Scholar
• Pannone G, Bufo P, Santoro A, et al. (2010). WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep 24:1035–41
   PubMed Web of Science ®Google Scholar
• Pepe MS, Etzioni R, Feng Z, et al. (2001). Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93:1054–61
   PubMed Web of Science ®Google Scholar
• Roy HK, Khandekar JD. (2007). Biomarkers for the early detection of cancer: an inflammatory concept. Arch Intern Med 167:1822–4
   PubMedGoogle Scholar
• Schatz P, Dietrich D, Koenig T, et al. (2010). Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation. J Mol Diagn 12:345–53
   PubMed Web of Science ®Google Scholar
• Semczuk A, Jakowicki JA. (2004). Alterations of pRb1-cyclin D1-cdk4/6-p16INK4A pathway in endometrial carcinogenesis. Cancer Lett 203:1–12
   PubMedGoogle Scholar
• Shen L, Waterland RA. (2007). Methods of DNA methylation analysis. Curr Opin Clin Nutr Metab Care 10:576–81
   PubMed Web of Science ®Google Scholar
• Shinojima Y, Terui T, Hara H, et al. (2010). Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation. J Dermatol Sci 59:98–106
   PubMedGoogle Scholar
• Spathis A, Aga E, Alepaki M, et al. (2011). Promoter methylation of p16INK4A, hMLH1, and MGMT in liquid-based cervical cytology samples compared with clinicopathological findings and HPV presence. Infect Dis Obstet Gynecol 2011:927861. doi: 10.1155/2011/927861
   PubMedGoogle Scholar
• Szalmas A, Konya J. (2009). Epigenetic alterations in cervical carcinogenesis. Semin Cancer Biol 19:144–52
   PubMed Web of Science ®Google Scholar
• Taby R, Issa JP. (2010). Cancer epigenetics. CA Cancer J Clin 60:376–92
   PubMed Web of Science ®Google Scholar
• Watanabe T, Yachi K, Ohta T, et al. (2010). Aberrant hypermethylation of non-promoter zygote arrest 1 (ZAR1) in human brain tumors. Neurol Med Chir (Tokyo) 50:1062–9
   PubMedGoogle Scholar
• Watanabe T, Yachi K, Ohta T, et al. (2011). Non-promoter hypermethylation of zygote arrest 1 (ZAR1) in human brain tumors. Brain Tumor Pathol 28:199–202
   PubMedGoogle Scholar
• Woodman CB, Collins SI, Young LS. (2007). The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7:11–22
   PubMed Web of Science ®Google Scholar
• Wu JH, Liang XA, Wu YM, et al. (2013). Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay. Oncol Rep 29:125–32
   PubMed Web of Science ®Google Scholar